A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants

Clinical trial NCT06597500 · COMPLETED

Trial details

NCT number: NCT06597500
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2024-09-30
Primary completion: 2024-12-16
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.